Oncogenic Ras in tumour progression and metastasis
- 1 January 2005
- journal article
- review article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 386 (3) , 193-205
- https://doi.org/10.1515/bc.2005.025
Abstract
The ras genes give rise to a family of related GTP-binding proteins that exhibit potent transforming potential. Mutational activation of Ras proteins promotes oncogenesis by disturbing a multitude of cellular processes, such as gene expression, cell cycle progression and cell proliferation, as well as cell survival, and cell migration. Ras signalling pathways are well known for their involvement in tumour initiation, but less is known about their contribution to invasion and metastasis. This review summarises the role and mechanisms of Ras signalling, especially the role of the Ras effector cascade Raf/MEK/ERK, as well as the phosphatidylinositol 3-kinase/Akt pathway in Ras-mediated transformation and tumour progression. In addition, it discusses the impact of Rho GTPases on Ras-mediated transformation and metastasis.Keywords
This publication has 157 references indexed in Scilit:
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Tumor progression: Small GTPases and loss of cell–cell adhesionBioEssays, 2003
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Direct integrin αvβ6-ERK binding: implications for tumour growthOncogene, 2002
- Pancreatic Tumor Cells with Mutant K-ras Suppress ERK Activity by MEK-Dependent Induction of MAP Kinase Phosphatase-2Biochemical and Biophysical Research Communications, 2001
- TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activationOncogene, 2000
- Rho-like GTPasesEuropean Journal Of Cancer, 1999
- Identification of AF-6 and Canoe as Putative Targets for RasJournal of Biological Chemistry, 1996
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994